000 01351 a2200349 4500
005 20250516122558.0
264 0 _c20130514
008 201305s 0 0 fre d
022 _a1769-664X
024 7 _a10.1016/S0929-693X(12)71283-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaunay, E
245 0 0 _a[Therapeutics strategies for the management of urinary tract infection in children].
_h[electronic resource]
260 _bArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_cNov 2012
300 _aS109-16 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlgorithms
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aEscherichia coli
_xdrug effects
650 0 4 _aEscherichia coli Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPyelonephritis
_xdrug therapy
650 0 4 _aUrinary Tract Infections
_xdrug therapy
650 0 4 _abeta-Lactamases
_xbiosynthesis
700 1 _aBingen, E
700 1 _aCohen, R
773 0 _tArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_gvol. 19 Suppl 3
_gp. S109-16
856 4 0 _uhttps://doi.org/10.1016/S0929-693X(12)71283-6
_zAvailable from publisher's website
999 _c22288400
_d22288400